CU Medicine provides primary and specialty healthcare services, self-described as a provider of healthcare solutions.

CU Medicine

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.

Metric
Company Name	CU Medicine	Teladoc Health, Inc.
Symbol		TDOC
MSH ID	US:CUMEDICINE	COM:TELADOCHEALTH
Market	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare
Industry	Healthcare	Medical - Healthcare Information Services
Country	US	US
Stage
Employee Count		4.82K
Website	cumedicine.us	teladochealth.com
LinkedIn
Founders

Metric
Market Cap		1.52B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue		2.60B
Revenue (LTM)
Revenue (NTM)
Gross Profit		1.84B
EBITDA		192.05M
Operating Income		-248.55M
Net Income		-220.37M
EPS		-1.34
Diluted EPS		-1.34
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.71
Operating Profit Margin		-0.10
EBITDA Margin		0.07
Net Profit Margin		-0.08
Return on Equity		-0.10
Return on Assets		-0.05
Return on Capital Employed		-0.06

US:CUMEDICINE

CU Medicine

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		-0.78
P/B Ratio		1.37
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		0.97
EV Multiple		-0.99

Metric
Days Sales Outstanding		29.13
Days Payables Outstanding		12.56
Days Inventory Outstanding		14.81
Operating Cycle		46.44
Cash Conversion Cycle		29.46
Asset Turnover		0.74

Metric
Operating Cash Flow		350.02M
Free Cash Flow		193.67M
Cash Flow to Debt		0.22
Operating Cash Flow/Sales		0.13
Free Cash Flow Yield		0.04

Metric
Cash & Equivalents		1.12B
Accounts Receivable		-10.25M
Inventory		29.51M
Goodwill		1.07B
Debt to Capitalization		0.51
Debt to Assets		0.37
Current Ratio		3.44
Quick Ratio		3.65

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.08
R&D to Revenue		0.13
SG&A to Revenue		0.19